The full edition of the report is available at Xinhua Silk Road Database. You can click the “Table of Content” to have a general understanding of it.
Click on the button below to create your account and get immediate access to thousands of articles.
Huadong Medicine completes equity investment in Heidelberg Pharma
Chinese pharmaceutical firm Huadong Medicine Co., Ltd. (Huadong Medicine, 000963.SZ) announced on Wednesday that its wholly-owned subsidiary Huadong Medicine Investment Holding (Hong Kong) Limited has finished the equity investment in Heidelberg Pharma in Germany on Tuesday and become the second largest shareholder of the company with 35 percent of its equity.
September08,2022
If you have any questions, please enter them in the box below.
Do you want to be a contributor to Xinhua Silk Road and tell us your Belt & Road story? Send your articles to silkroadweekly@xinhua.org and share your stories with more people.
Click on the button below to create your account and get im http://img.silkroad.news.cn/templates/silkroad/en2017te access to thousands of articles.
